|
Mezigdomide Clinical Trials
11 actively recruiting trials across 7 locations
▲ +1 trial since July 2026
Also known as: BMS 986348, BMS-986348, BMS986348, CC 92480, CC-92480 +4 more
Pipeline
Phase 1: 4Phase 2: 1Phase 3: 1Phase 1/2: 5
Top Sponsors
- Memorial Sloan Kettering Cancer Center2
- Celgene2
- YOUNGIL KOH1
- Roswell Park Cancer Institute1
- Massachusetts General Hospital1
Indications
- Cancer11
- Multiple Myeloma6
- Relapsed Refractory Multiple Myeloma (RRMM)2
- Extramedullary Disease in Multiple Myeloma1
- Recurrent Multiple Myeloma1
Duarte, California3 trials
A Study of Revumenib and Mezigdomide in People With Leukemia
City of Hope Cancer Center (Data collection only)
Phase 1/2
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
City of Hope National Medical Center /ID# 273132
Phase 1/2
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
City of Hope Medical Center
Phase 1
Birmingham, Alabama2 trials
Other1 trial
Gilbert, Arizona1 trial
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Banner MD Anderson Cancer Center
Phase 1/2
Los Alamitos, California1 trial
Boston, Massachusetts1 trial
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
Massachusetts General Hospital
Phase 1
Basking Ridge, New Jersey1 trial
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Phase 1
Buffalo, New York1 trial
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Roswell Park Cancer Institute
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.